Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This chapter reviews the available options for camouflaging hair loss and thinning, discussing their advantages and disadvantages, but reports no new clinical results.

This article compiles internet forum posts discussing differences between brand-name and generic finasteride pills, but it presents no new clinical findings.

This study will evaluate the clinical efficacy, patient-reported outcomes, and economic impact of the PAXMAN® PSCS 2 automated scalp cooling system versus standard cold-cap therapy to prevent chemotherapy-induced hair loss in women with localized breast cancer during anthracycline and taxane treatment.

In this study, researchers found that ritlecitinib 50 mg offered a lower cost per responder than baricitinib 2 or 4 mg at both 24 and 52 weeks for treating severe alopecia areata, suggesting potential implications for reimbursement or formulary decisions.

This article reviews the diagnostic challenges of polycystic ovary syndrome in adolescents, discussing criteria, symptoms overlap with normal puberty, and treatment strategies, but it reports no new clinical findings.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

This study found that adjuvant docetaxel chemotherapy is linked to higher rates of dissatisfaction and chronic alopecia compared to paclitaxel chemotherapy, suggesting these outcomes should be discussed with patients before using docetaxel regimens.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

Tailored medication preparation and ongoing education are crucial for effective treatments.

This thesis explored the relationship between wholesale and retail prescription drug prices and concluded that unexpected negative mark-ups and inaccurate wholesale price comparisons suggest further investigation is needed.

In this large retrospective study, patients using compounded topical finasteride and minoxidil through a telehealth platform for male androgenetic alopecia reported high satisfaction and low incidence of side effects, with no need for higher care or treatment discontinuation due to adverse reactions.

This study found that persistent significant alopecia was a common side effect following FEC-docetaxel chemotherapy, with a 33.4% global incidence, highlighting the need for awareness and potential preventative measures like cooling caps during treatment.

This study found that over 80% of women treated with paclitaxel who used a hypothermic glycerin-based hydrogel cap preserved at least 50% of their initial hair volume, suggesting scalp cooling may effectively prevent chemotherapy-induced alopecia.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

This study found that using at least one ICD-10 code for alopecia in Medicaid claims data accurately identified alopecia in women of childbearing age, with positive predictive values between 95.3% and 100% across various algorithms tested.

This study found that the oral contraceptive containing drospirenone (EE/DRSP) was as effective as EE/CPA in reducing acne lesions, sebum production, and hair growth in women with acne.

The authors concluded that preoperative treatment with finasteride for a month effectively reduced perioperative bleeding and shortened hospital stays in patients undergoing transurethral resection of the prostate.

This study observed that women using combined oral contraceptives experienced more nausea, vomiting, and hair loss, while those on Depo-Provera were more likely to gain weight.

This article discusses the introduction and market presence of the Italian hair product Kevis but presents no new clinical findings.

This study found that the HPCH-based formulation P-08–016 may facilitate finasteride deposition in the dermis, potentially offering an alternative to systemic therapy by minimizing systemic absorption.

This report from a consensus meeting concluded that while 5-alpha reductase inhibitors are beneficial for BPH treatment and prostate cancer risk reduction, their role in clinical practice should be more widely integrated into prostate management guidelines.

Method quickly measures finasteride concentration in capsules.

In this study, caregivers of patients with chronic skin diseases such as psoriasis, vitiligo, and alopecia areata reported significant burdens, including stress and lack of time, which negatively impacted their quality of life, particularly in those caring for psoriasis patients.